$TREX

TREX COMPANY REPORTS RECORD REVENUE AND STRONG Second QUARTER 2026 RESULTS

TREX CO INC (TREX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 News release TREX COMPANY REPORTS RECORD REVENUE AND STRONG Second QUARTER 2026 RESULTS Broad Based Volume-driven Growth Across Product Lines, Price Points and Channels Accelerating Timing of Arkansas Expansion to Meet Increased Consumer Demand; Expected to Operate a

Original reporting
Published Aug 4, 2026, 10:30 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 4, 2026, 10:32 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$TREX
Bullish
medium confidence
Mentioned
$TREX
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$TREXBullishMed
01

Why it matters

The filing provides fresh, decision-relevant inputs: record revenue, updated operational timing (Arkansas ramp to Q3 2026), distribution model progress, Q2 profitability/FCF, and reaffirmed full-year 2026 guidance alongside an additional $150M buyback authorization.

02

Market read

Traders can update near-term expectations for revenue growth, margin trajectory, and capital return based on the reaffirmed guidance range, Q2 profitability/FCF, and the accelerated capacity ramp.

03

What to watch

Higher SG&A as Trex invests in branding and marketing, plus the reliance on utilization improvement after uneven demand, could delay margin recovery even if revenue growth continues.

Relevance 7/10Novelty 8/10Timing: pre-market today (8-K earnings release filed Aug 4, 2026)
AlphAI · Earnings readTREX · Q2 2026 · ended June 30, 2026

TREX COMPANY REPORTS RECORD REVENUE AND STRONG Second QUARTER 2026 RESULTS

→Mixed quarter

Net sales increased 8% to $418 million on volume-driven, broad-based demand, but gross margin declined to 37.9% and GAAP and adjusted earnings both fell from the prior-year period.

Revenue
$418M
increased 8% y/y
Gross margin · GAAP
37.9%
EPS · non-GAAP
$0.62
Full Year 2026 and Q3 2026 outlook
Full Year 2026 net sales: $1.215B to $1.250B; Q3 2026 net sales: $305M - $320M

Key metrics

shortened, hover for the filing’s print
MetricValueq/qy/y
Net salesGAAP$418M–increased 8%
Gross profitGAAP$158M––
Gross marginGAAP37.9%––
Adjusted gross profitnon-GAAP$158.3M––
Selling, general, and administrative expensesGAAP$67M––
Selling, general, and administrative expenses as a percentage of net salesGAAP16.1% of net sales––
Adjusted SG&Anon-GAAP$66M––
Net incomeGAAP$62M––
Diluted earnings per shareGAAP$0.60 per diluted share––
Adjusted net incomenon-GAAP$63M––
Adjusted diluted earnings per sharenon-GAAP$0.62––
Adjusted EBITDAnon-GAAP$112M––
Free cash flownon-GAAP$182M––
Six months ended June 30 net incomeGAAP$123.3M––
Six months ended June 30 diluted earnings per shareGAAP$1.19––
Six months ended June 30 adjusted net incomenon-GAAP$125.5M––
Six months ended June 30 adjusted diluted earnings per sharenon-GAAP$1.21––

Full Year 2026 and Q3 2026 outlook

  • RevenueFull Year 2026 net sales: $1.215B to $1.250B; Q3 2026 net sales: $305M - $320M
  • Operating expensesSG&A: ~18% of net sales
  • Tax rate25.5% to 27.0%
  • NoteFull Year 2026 Adjusted EBITDA: $335M to $350M
  • NoteDepreciation and amortization: ~$85M
  • NoteInterest expense: $8M to $10M
  • NoteCapEx: $100M to $120M

Capital returns

  • During the quarter, the Company repurchased approximately $51 million in shares.
  • In July, the Board of Directors approved up to $150 million in share repurchases during the back half of the year.

What drove it

  • Net sales growth was driven primarily by volume, with pricing contributing minimally to the increase.
  • The Company cited broad-based strength across product categories, price points, and distribution channels.
  • The Company saw particularly strong demand for entry-level Trex Enhance® decking.
  • The distribution-model transition was tracking to plan, with inventory levels at distributors already at desired levels.
  • Trex accelerated the ramp-up of decking production in its Arkansas facility by more than six months to the third quarter of 2026.

Concerns

  • Gross margin was impacted by a higher mix of railing sales, increased depreciation expense associated with the Arkansas facility, and temporary production inefficiencies.
  • Production utilization was lower early in the period before stronger than expected order activity in the final month.
  • Selling, general, and administrative expenses increased primarily due to investments in capabilities and continued branding and marketing programs.
  • Adjusted diluted EPS included a negative impact of approximately $0.03 related to a $5 million non-cash write-down of obsolete equipment.

What to watch

  • Utilization improvement following strong order activity in July.
  • The Arkansas facility ramp-up, which is expected to operate at 50% capacity by year end.
  • Execution of the upgraded distribution model and distributor inventory levels.
  • Progress toward full-year 2026 net sales guidance of $1.215B to $1.250B and adjusted EBITDA guidance of $335M to $350M.
  • Third quarter net sales relative to guidance of $305M - $320M.

Balance sheet and cash flow

  • Free cash flow for the quarter was $182 million, reflecting the seasonal benefit of working capital and lower capital expenditures as the Arkansas facility approaches full completion.
  • During the quarter, the Company repaid $130 million outstanding under its revolving credit facility.

Analysis

Trex reported record second-quarter net sales of $418 million, up 8% from $388 million in the prior-year period. The company attributed the increase primarily to volume, with minimal pricing contribution, and described demand as broad-based across product categories, price points, and distribution channels. Management specifically highlighted strong demand for entry-level Trex Enhance® decking and improved consumer demand trends.

Revenue growth did not translate into higher profit. Gross profit was $158 million, essentially unchanged from $158 million in the prior-year period, while gross margin declined to 37.9% from 40.8%. Trex attributed the margin pressure to a higher mix of railing sales, Arkansas-related depreciation, and temporary production inefficiencies from uneven demand patterns. Adjusted EBITDA was $112 million compared with $122 million in the prior-year period, while GAAP net income was $62 million compared with $76 million.

Expenses also increased. SG&A was $67 million, or 16.1% of net sales, compared with $56 million, or 14.4% of net sales. The company cited investments in capabilities, branding, and marketing programs. Adjusted diluted EPS was $0.62 compared with $0.73, and included an approximately $0.03 negative impact from a $5 million non-cash write-down of obsolete equipment.

Cash generation and capital allocation were notable. Free cash flow was $182 million, supported by seasonal working-capital benefits and lower capital expenditures as the Arkansas facility approaches full completion. Trex repurchased approximately $51 million in shares and repaid $130 million outstanding under its revolving credit facility. The Board also approved up to $150 million in share repurchases during the back half of the year.

Trex reaffirmed its recently raised full-year 2026 outlook for net sales of $1.215B to $1.250B and adjusted EBITDA of $335M to $350M, while providing Q3 net sales guidance of $305M - $320M. Management expects stronger order activity in July to support improved utilization. The Arkansas ramp was accelerated to the third quarter of 2026 and is expected to operate at 50% capacity by year end, positioning the site as an expected future margin and capacity driver.

Management, verbatim

I’m pleased to report that Trex is delivering strong results from disciplined execution against our strategic priorities. We are returning to stronger top-line growth, while also upgrading our distribution network and accelerating the timing of our Arkansas capacity expansion to further strengthen our market position and drive long-term growth,

Adam Zambanini, President and CEO

Together, our accelerated Arkansas expansion and upgraded distribution network strengthens our competitive position, supports long-term growth, and advances our goal of achieving $2 billion in annual sales by 2030,

Adam Zambanini, President and CEO

Additionally, we continue to generate significant free cash flow as our multi-year capital investment program nears completion. This financial strength allows us to reduce leverage while returning capital to shareholders through share repurchases, consistent with our disciplined and balanced capital allocation strategy,

Prith Gandhi, Senior Vice President and CFO

Not in the filing

stated, not guessed
  • GAAP operating income
  • GAAP operating margin
  • Cash balance
  • Total debt balance
  • Dividend amount or dividend activity
  • Segment revenue
  • Segment revenue comparisons
  • Prior-quarter comparisons for reported metrics
  • Q3 2026 gross margin guidance
  • Q3 2026 adjusted EBITDA guidance
  • Previous-release outlook needed to compare actual results with prior guidance

AlphAI analysis generated from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure was cross-checked against the filing text; consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.

Background

This is Trex’s SEC Form 8-K reporting Q2 2026 results (Item 2.02) with an attached earnings release (Exhibit 99.1).

Company-level read

Ticker impact

$TREXBullishMedium confidence
Context

Trex reported Q2 2026 net sales of $418M, gross margin of 37.9%, and reaffirmed full-year 2026 guidance with $150M additional buybacks approved.

Expected impact

Moderately positive bias for the next few sessions as traders price in stronger demand and capacity timing, with sensitivity to any follow-through on utilization and margin.

Evidence & confidence

The filing is a primary earnings release with specific datapoints (sales, margins, FCF, buyback authorization) and a concrete operational catalyst (Arkansas ramp accelerated to Q3 2026). However, gross margin declined YoY and adjusted EBITDA fell, so the market may wait for confirmation in subsequent quarters.

Market effects

Composite decking peers may see read-across demand and wood-to-composite conversion momentum, especially if Arkansas capacity timing improves industry supply and pricing discipline.

Sunbelt demand servicing via the Arkansas facility could shift regional inventory dynamics and logistics costs for outdoor living products.

Limited direct global impact, but sustainability and capacity expansion narratives can influence investor sentiment across US home-improvement supply chains.

Counterpoint

Margin compression in Q2 (37.9% vs 40.8% prior year) and temporary production inefficiencies suggest the improved demand may not immediately translate into earnings power.

Key entities

  • Trex Company, Inc.

    Composite decking and railing manufacturer reporting Q2 2026 results and reaffirmed full-year 2026 guidance.

  • Adam Zambanini

    CEO quoted on demand trends, distribution upgrades, and accelerated Arkansas capacity timing.

  • Prith Gandhi

    CFO quoted on reaffirmed guidance and margin expansion expectations from Arkansas utilization.

Every TREX earnings report

This story covers one filing. The ticker page keeps them all: each quarter's reported metrics with year-over-year and sequential comparisons, segments, guidance, and how the numbers landed against the company's own prior outlook.

Related articles

HighAI 8/10

TRex Bio, Clinical-Stage Immunology Biopharma, Files for Nasdaq Global Select Market IPO

TRex Bio filed for a Nasdaq IPO, offering 8,333,334 shares at $14.00 each, aiming to raise $116.7 million. The company, focused on immunoregulatory medicines, plans to use proceeds for clinical trials and general corporate purposes. Eli Lilly has shown interest in purchasing shares. TRex Bio's lead candidate, TRB-061, is in Phase 1b trials for atopic dermatitis, with data expected in mid-2027.

HighAI 8/10

TRex Bio raises $116.7 million in IPO priced at $14 a share

TRex Bio Inc. raised $116.7 million in its IPO, priced at $14 per share. J.P. Morgan and Evercore led the offering, indicating institutional confidence. The company focuses on immunology, an area of sustained investor interest. All shares were pre-allocated to institutional buyers, with the first public trading opportunity upcoming.

HighAI 8/10

TRex Bio IPO raises $116.7 million, prices at bottom of range

TRex Bio Inc. raised $116.7 million in its U.S. IPO, pricing shares at $14, the bottom of its $14-$16 range. The biotech company sold 8.3 million shares, giving it a market value of about $384 million. Proceeds will fund clinical trials for its lead drug candidate, TRB-061. Shares will trade on Nasdaq under the ticker TRXB. The company reported a net loss of $34.8 million in 2025, up from $3.1 million the prior year.

HighAI 8/10

TRex Bio prices $117M IPO to support immune drug work

TRex Bio priced its IPO at $117M, selling 8.3M shares at $14 each, and will trade on Nasdaq under 'TRXB'. The company is developing immune drugs, with TRB-061 in Phase 1 trials and TRB-071 planned for testing. Eli Lilly, its largest shareholder, may also buy IPO shares. TRex has raised $220M in venture financing. Another biotech, Retension Pharmaceuticals, also went public with a $45M offering, highlighting increased biotech IPO activity in 2026.

HighAI 9/10

TRex Bio, Inc. Prices $116.7M IPO at $14

TRex Bio priced 8.3M shares at $14 each, raising $116.7M in its IPO. Trading begins Oct. 9 on Nasdaq under ticker TRXB. Underwriters have a 30-day option for 1.25M more shares. The company plans to use proceeds for its clinical-stage immunology pipeline.